Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for ...
Advancing RNA therapeutics depends on understanding two critical questions: Where do drug candidates go, and what do they do ...
Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...
The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication ...
Researchers have identified OTULIN, an immune-regulating enzyme, as a key trigger of tau buildup in the brain. When OTULIN ...
A research team has uncovered and reconstructed the complete biosynthetic pathway of polyphyllin II—a potent anticancer ...
Researchers at VIB and KU Leuven have identified a molecular process that allows motor neurons to maintain protein production ...
Researchers at VIB and KU Leuven have identified a molecular process that allows motor neurons to maintain protein production, a process that fails in amyotrophic lateral sclerosis (ALS).
As genetic engineering technologies such as clustered regularly interspaced short palindromic repeats (CRISPR) improve and ...